Part, Chapter, Paragraph
1 -, 1 | from a few exceptions, each Chapter of this Report, constituting
2 I, 2. 1 | 2.1. Introduction~ ~This Chapter deals with a number of demographic,
3 I, 2. 9 | fires) are dealt with in Chapter 10.~ ~ ~
4 II, 4. 1 | in good health.~ ~In this chapter we present the first HLY
5 II, 5. 2. 3 | cancer.~As explained in chapter 5.2.2 ‘Data sources’, it
6 II, 5. 2. 3 | age of 75. As explained in chapter 4.2.2 ‘Data sources’, it
7 II, 5. 2. 4 | Eastern countries (see also Chapter 8).~ ~Table 5.2.7. Estimated
8 II, 5. 2. 4 | Panico et al, 2008) (see Chapter 5.1.4). Recent evidence
9 II, 5. 2. 4 | predicting CV risk (see also Chapter 10).~ ~Table 5.2.10. Estimated
10 II, 5. 2. 4 | never been smokers (see Chapter 5.1.2.).~Unfortunately,
11 II, 5. 3. 1 | Capocaccia et al, 2003), in this chapter cancer outcome indicators
12 II, 5. 3. 2 | networks and projects~ ~This chapter uses data, information and
13 II, 5. 3. 4 | included in the present chapter.~ ~Stomach cancer: It has
14 II, 5. 3. 7 | Boyle et al, 2003).~ ~See Chapter 10 for primary prevention
15 II, 5. 3. 7 | For further details see Chapter 4.14.~ ~
16 II, 5. 4. 6 | healthy lifestyles. See Chapter 5.13. on overweight and
17 II, 5. 4. 6 | and high cholesterol, see Chapter 5.2.4. and for other risk
18 II, 5. 4. 6 | for other risk factors see Chapter 10.~To prevent the occurrence
19 II, 5. 4. 7 | as shown before in this chapter, have paved the ground for
20 II, 5. 5. 1 | survey are presented in Chapter 5.5.1. Mental Disorders.
21 II, 5. 5. 1 | are presented in detail in Chapter 5.5.1. Mental Disorders.
22 II, 5. 5. 1 | presented in more detail in Chapter 5.5.1. Mood Disorders.~ ~ ~
23 II, 5. 5. 2 | well-being in later life, Chapter 6, available at: htt m (
24 II, 5. 5. 3 | from the 2001/2002 survey, chapter 3, 110-129. WHO Library
25 II, 5. 5. 3 | to ICD-10/F20, i.e. the chapter including schizophrenia,
26 II, 5. 5. 3 | actively screened for; in this chapter we have highlighted the
27 II, 5. 6. 1 | biopsychosocial mechanisms. This chapter will consider musculoskeletal
28 II, 5. 6. 2 | 2005)~ ~The content of this chapter uses material and data from
29 II, 5. 6. 6 | Mosby-Elsevier; Section C, Chapter 1.~Zollman C, Vickers A (
30 II, 5. 7. 5 | Primary prevention~ ~See Chapter 8~ ~Secondary prevention~ ~
31 II, 5. 7. 6 | donation rates ( see also the Chapter 9.2. on Transplants).~ ~
32 II, 5. 9. 2 | which are dealt with in the chapter, with reference to ICD 9:~·
33 II, 5. 9. 5 | lifestyles or the environment see Chapter 5. A key message related
34 II, 5. 11. 2 | 2. Data sources~ ~ ~This chapter is based on data and information
35 II, 5. 11. 3 | tumours and others (See Chapter 4.3).~Some skin diseases
36 II, 5. 11. 3 | Lidén, M Bruze, T Menné, Chapter 41 Metals. In: Textbook
37 II, 5. 11. 3 | European enterprises (see also Chapter 7 on “Rare Diseases”).~ ~
38 II, 5. 12. 1 | causing liver cirrhosis, this Chapter can be read in connection
39 II, 5. 12. 1 | the relevant Sections of Chapter 6.~ ~
40 II, 5. 12. 4 | HCV) infection (see also Chapter 6) and alcohol drinking (
41 II, 5. 12. 4 | association with HBV and HCV (see Chapter 6), cirrhosis mortality
42 II, 5. 12. 5 | of HBV vaccination (sse Chapter 6), control of HCV transmission (
43 II, 5. 12. 5 | of HCV transmission (see Chapter 6) and of alcohol drinking.~ ~
44 II, 5. 12. 5 | European countries.~See Chapter 8 for what concerns prevention
45 II, 5. 12. 5 | disease and death ( see also Chapter 6).~ ~There is inadequate
46 II, 5. 13 | diseases are dealt with in Chapter 10.2.1.7 in view of the
47 II, 5. 13 | the quoted references, see Chapter 10.2.1.7.~ ~ ~
48 II, 5. 14. 5 | the control of smoking see Chapter 8; for the control of excessive
49 II, 5. 14. 5 | alcohol consumption see Chapter 8 ; and for diabetes mellitus
50 II, 5. 14. 5 | for diabetes mellitus see Chapter 5.4.~It is possible to develop
51 II, 6. 1 | 6.1. Introduction~ ~This chapter gives an overview and outlines
52 II, 6. 1 | the main purposes of this chapter is to identify those diseases
53 II, 7. 1 | Promotion, 2008).~ ~This chapter provides the most recent
54 II, 7. 1 | elderly citizens.~ ~This chapter provides a general overview
55 II, 7. 1 | Council Recommendation (chapter “data discussion”), and
56 II, 7. 2. 1 | and injuries~ ~ICD-10:~- Chapter XIX: Injury, poisoning and
57 II, 7. 2. 1 | external causes ~ (S00-T98).~- Chapter XX: External causes of morbidity
58 II, 7. 2. 1 | mortality (V01-Y98)~ ~ICD-9:~- Chapter 17 on INJURY AND POISONING (
59 II, 7. 2. 1 | with respect to the ICD-10 chapter XX; ICECI does not replace
60 II, 7. 2. 1 | does not replace this ICD chapter but rather includes the
61 II, 7. 2. 2 | discharges by diagnosis (ICD10 Chapter XIX) and average length
62 II, 7. 2. 2 | accidents and injuries - ICD10 Chapter XX – is only sporadically
63 II, 7. 3 | main data source for this chapter is the “Report on Injuries
64 II, 7. 3 | The figures stated in this chapter represent a yearly average
65 II, 7. 3. 4 | figures are described in Chapter 6.2. Figure 7.12. Non-fatal
66 II, 7. 3. 4 | etc. (see also “IDB” in Chapter 6.2).~ ~
67 II, 7. 4 | The survey of the previous chapter clearly shows the public
68 II, 7. 4 | detail later on in this chapter:~ ~· Children and adolescents;~·
69 II, 8. 2. 1 | References included in this Chapter represent recent studies
70 II, 8. 2. 1 | health inequalities (see the chapter on policies related to overall
71 II, 9 | GENDER~POPULATION GROUPS~This chapter deals with the main health
72 II, 9 | anomalies are listed in Chapter 9.1.2; references cited
73 II, 9 | paragraphs are listed in Chapter 9.1.1~ ~ ~ ~Table 9.1b.
74 II, 9 | this table are listed in Chapter 9.2~ ~ ~Table 9.1c. Main
75 II, 9 | this table are listed in Chapter 9.3.1~ ~ ~Table 9.1d. Main
76 II, 9 | this table are listed in Chapter 9.4~ ~ ~ ~
77 II, 9. 1 | nearly half of the cases (see chapter 9.3.2).~ ~This burden of
78 II, 9. 1. 1 | Congenital malformations~ ~See Chapter 9.1.2 for a detailed and
79 II, 9. 1. 1 | in EU Member States. See Chapter 9.3.2 for more information.~ ~ ~
80 II, 9. 1. 1 | the data presented in this chapter reveal significant geographic
81 II, 9. 1. 1 | reproduction issues is presented in Chapter 9.3.2~ ~
82 II, 9. 1. 2 | elsewhere in this Report (see Chapter 5). Metabolic diseases diagnosed
83 II, 9. 1. 2 | Their data can be seen in Chapter 4.1. Such infant mortality
84 II, 9. 1. 2 | Europe is documented in Chapter 8. Figure 9.1.2.2 shows
85 II, 9. 1. 2 | anomalies are listed in Chapter 9.1.2; references cited
86 II, 9. 1. 2 | paragraphs are listed in Chapter 9.1.1~ ~ ~ ~ ~
87 II, 9. 1. 2 | Most rare diseases (see Chapter 5.15) are congenital. The
88 II, 9. 2. 3 | countries in recent years (see Chapter 4.1). Congenital malformations
89 II, 9. 2. 3 | mortality in neonates (see Chapter 4.2), and accidents for
90 II, 9. 2. 3 | for 5-14 year olds (see Chapter 7).~ ~Cancer: Tumors recognized
91 II, 9. 2. 3 | adolescents can be found in chapter “9.3.3. Sexual health”~ ~
92 II, 9. 2. 3 | health (WHO 2005c)(see also Chapter 9.3).~ ~The incidence rate
93 II, 9. 2. 3 | type two diabetes(see also Chapter 5).~ ~Excess body weight
94 II, 9. 2. 4 | this table are listed in Chapter 9.2~ ~ ~
95 II, 9. 2. 5 | for specific diseases in Chapter 5 and for specific health
96 II, 9. 2. 5 | specific health determinants in Chapter 10.~ ~Healthcare and services~ ~
97 II, 9. 3. 1 | issues not dealt with in this Chapter see Chapter 9.5.~ ~ ~
98 II, 9. 3. 1 | with in this Chapter see Chapter 9.5.~ ~ ~
99 II, 9. 3. 1 | and women is provided in chapter 9.5.~ ~As compared to women,
100 II, 9. 3. 1 | data bases utilised in this chapter also include WHOSIS, GLOBOCAN,
101 II, 9. 3. 1 | as compared to women (see Chapter on Accidents), with the
102 II, 9. 3. 1 | cancer types are described in Chapter 5.3.~ ~Circulatory diseases~ ~
103 II, 9. 3. 1 | diseases are described in Chapter 5.2.~ ~A man with metabolic
104 II, 9. 3. 1 | this table are listed in Chapter 9.3.1~ ~ ~ ~
105 II, 9. 3. 1 | for specific diseases in Chapter 5 and for specific health
106 II, 9. 3. 1 | specific health determinants in Chapter 10. For issues concerning
107 II, 9. 3. 1 | concerning health services see Chapter 11.~ ~
108 II, 9. 3. 2 | health have been presented in Chapter 9.1.1.2.~ ~
109 II, 9. 3. 3 | sources for the present chapter are:~ ~· The European Concerted
110 II, 9. 3. 3 | violence is included in the Chapter dedicated to “Special gender-related
111 II, 9. 4. 3 | risk factor in men (see chapter on dementia for further
112 II, 9. 4. 4 | this table are listed in Chapter 9.4~ ~ ~ ~
113 II, 9. 4. 5 | for specific diseases in Chapter 5 and for specific health
114 II, 9. 4. 5 | specific health determinants in Chapter 10.~ ~As far as control
115 III, 10. 2. 1 | deaths in both sexes (see Chapter 5.2.). Smoking contributes
116 III, 10. 2. 1 | al., 1998).~Cancers (see Chapter 5.3) of the respiratory
117 III, 10. 2. 1 | Mortality due to COPD (see Chapter 5.7) varies from country
118 III, 10. 2. 1(2)| Not analyzed in this chapter.~
119 III, 10. 2. 1 | Data provided in this chapter, unless otherwise indicated,
120 III, 10. 2. 1 | behaviour is provided in chapter 9.3.3., within the more
121 III, 10. 2. 1 | study will be used for this chapter (Fig. 2 and 3).~ ~Selected
122 III, 10. 2. 2 | details and references, see Chapter 5.2.~ ~ ~
123 III, 10. 2. 3 | details and references, see Chapter 5.2.~ ~ ~
124 III, 10. 2. 4 | be described later in the Chapter no indicators for the implementation
125 III, 10. 2. 4 | rare genetic disorders (see Chapter 7 on Rare Diseases). These
126 III, 10. 2. 5 | different age groups see Chapter 9.~ ~
127 III, 10. 3. 1 | remains unclear.~ ~This chapter deals with different types
128 III, 10. 3. 2 | and pharmaceuticals. This chapter mainly deals with industrial
129 III, 10. 3. 2 | contaminants are only dealt with in Chapter 8.2.2 and not in the present
130 III, 10. 3. 2 | 2 and not in the present Chapter.~ ~
131 III, 10. 3. 2 | 2.2. Data sources~ ~This chapter is primarily based on extracts
132 III, 10. 3. 2 | the Fourth assessment (chapter on chemicals), and the EEA /
133 III, 10. 3. 2 | guidelines – Second Edition Chapter 6.11 Platinum. WHO Europe.
134 III, 10. 3. 3 | 3.2. Data sources~ ~See Chapter 6.~ ~
135 III, 10. 3. 3 | tools and policies~ ~See Chapter 6.~ ~ ~
136 III, 10. 3. 3 | Future developments~ ~See Chapter 6.~ ~ ~
137 III, 10. 3. 3 | 3.3.6. References~ ~See Chapter 6.~ ~
138 III, 10. 3. 4 | 78.000 Million Euro. This chapter presents first of all an
139 III, 10. 3. 4 | briefly mentioned in this chapter. With regard to heat, the
140 III, 10. 4. 1 | 2. Data Sources~ ~ ~This chapter is based on the European
141 III, 10. 4. 1 | building blocks of this chapter, as well as several DG Research
142 III, 10. 4. 2 | specified in its Annex III, Chapter A. At the beginning of 2005,
143 III, 10. 4. 2 | Article 6.4 specified in Chapter B.I of Annex III of the
144 III, 10. 4. 2 | pesticides. Particularly, Chapter V (articles 26 through 34)
145 III, 10. 4. 2 | Section on “Biomonitoring” in Chapter 8.1.2. has pointed out how
146 III, 10. 4. 2 | health loss in DALYs (see chapter 9.1).~ ~
147 III, 10. 4. 2 | of both feed and food.~ ~Chapter II of the Regulation seeks
148 III, 10. 4. 4 | piercing see Annex 1 of Chapter 5.13.~ ~The increasing production,
149 III, 10. 4. 4 | from the manufacturing (see Chapter 8.1.2.) and use of consumer
150 III, 10. 4. 4 | adequately enforced (see also Chapter 7). To facilitate this,
151 III, 10. 4. 4 | PROSAFE) www g (see also Chapter 7).~ ~ ~
152 III, 10. 4. 5 | especially relevant for this chapter is hazardous waste, EU waste
153 III, 10. 5. 1 | sources~ ~The data in this chapter is mostly taken from scientific
154 III, 10. 5. 1 | Legionella Pneumophila (see chapter 6).~ ~Construction materials
155 III, 10. 5. 1 | Lebensmittelsicherheit, 2008) (see chapter 6 for fatal and non-fatal
156 III, 10. 5. 1 | cities provided by this chapter is a very weak indication
157 III, 10. 5. 2 | sources~ ~The data in this chapter is mostly taken from scientific
158 III, 10. 5. 2 | the data presented in this chapter are based on sources which
159 III, 10. 5. 2 | findings discussed in this chapter therefore strongly depend
160 III, 10. 5. 3 | as health problems. This chapter therefore takes two perspectives.
161 III, 10. 5. 3 | the world of work~ ~This chapter presents the impact of diseases
162 III, 10. 5. 3 | morbidity and disability~ ~This chapter addresses the impact of
163 III, 10. 5. 3 | risk environment”. In this chapter, the impact of work on disease
164 III, 10. 5. 3 | fatal accidents see also Chapter 7.~ ~Table 10.5.3.5. Incidence
165 III, 10. 5. 3 | tools and policies~ ~In this chapter it is pointed out that interventions
166 III, 10. 5. 3 | activities. One aim of this chapter is to point out the common
167 III, 10. 6. 2 | countries. The last part of this chapter illustrates some strategies
168 III, 10. 6. 3 | homicides, are quoted in Chapter 7.~ ~ ~
169 III, 10. 6. 3 | has been carried out in Chapter 7 (See figure 7.17).~ ~Contact
170 IV, 11. 1. 1 | system.~ ~The aim of this chapter, therefore, is to familiarize
171 IV, 11. 1. 1 | therefore important. This chapter thus provides an overview
172 IV, 11. 1. 1 | Primarily a descriptive chapter, the discussion begins with
173 IV, 11. 1. 1 | outside the scope of this chapter. The supply of resources
174 IV, 11. 1. 1 | the outset that while this chapter adopts a European comparative
175 IV, 11. 1. 1 | pursued, the purpose of this chapter is to provide a solid starting-point.~ ~
176 IV, 11. 1. 2 | 1.2. Data sources~ ~This chapter draws on a number of international
177 IV, 11. 1. 2 | database where necessary, the chapter draws on the OECD health
178 IV, 11. 1. 2 | international data sources, the chapter also makes use of European
179 IV, 11. 1. 2 | health care. Finally, the chapter draws on published reports
180 IV, 11. 1. 3 | as shown throughout this chapter, there are important differences
181 IV, 11. 1. 3 | Although not the focus of this chapter, within this context of
182 IV, 11. 1. 3 | again fall outside this chapter. Nevertheless, the increased
183 IV, 12. 2 | in all policies (see also Chapter 11.5) and global health
184 IV, 12. 2 | level. To this end, each chapter dealing with a specific
